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Abstract
Purpose: This study examined the effects of a widely used (Delton® Pit & 
Fissure Sealant – Light Cure Opaque, DENTSPLY Professional, York, PA) 
pit and fissure sealant material on bisphenol A (BPA) levels in blood and 
saliva, among both low and high–dose groups over time.
Methods: A convenience sample of 30 adults from the Old Dominion Uni-
versity population were randomly and evenly divided into 2 independent 
variable groups: a low–dose group (1 occlusal sealant application) and 
high–dose group (4 occlusal sealant applications). A 2 group, time series 
design was used to examine the presence and concentration of BPA in se-
rum and saliva after sealant placement. Differences comparing low–dose 
and high–dose groups were examined 1 hour prior (baseline), 1 hour post, 3 
hours post and 24 hours after sealant placement, as measured by a direct–
competitive BPA Enzyme Linked ImmunoSorbent Assay (ELISA). Hypoth-
esized outcomes were evaluated by applying a parametric, 2 way ANOVA 
for repeated measures technique to data on the 30 participants ranging in 
age from 18 to 40 years, and were of mixed gender and ethnicity.
Results: BPA was detected in the saliva of all participants prior to sealant 
placement and ranged from 0.07 to 6.00 ng/ml at baseline. Salivary BPA 
concentration levels peaked over a 3 hour period following sealant place-
ment and returned to baseline levels within 24 hours. BPA was significantly 
elevated at all post–sealant placement time periods for both the low–dose 
(1 occlusal sealant application) and high–dose (4 occlusal sealant applica-
tions) groups with peak levels of 3.98 ng/ml and 9.08 ng/ml, respectively. 
The blood serum did not contain BPA at any point in this investigation.
Conclusions: Exposure to BPA from sources other than dental resins con-
tributes to salivary baseline concentration levels and indicates environmen-
tal exposure and use of products containing BPA. Use of specific molecu-
lar formulations of dental sealant material determines the release of BPA, 
therefore, dental sealant materials should be reviewed independently when 
questioning the release of BPA from dental sealants. In addition, dosage 
amounts of the dental sealant material used in this study do not influence 
the serum concentration levels of BPA. Further research is needed to ex-
amine the cumulative estrogenic effects of BPA from dental sealants.
Keywords: sealants, dental, bisphenol A, estrogenic
This study supports the NDHRA priority area, Occupational Health and 
Safety: Investigate methods to decrease errors, risks and or hazards in 
health care and their harmful impact on patients.
Occlusal sealants in perma-
nent molars demonstrate caries–
preventive effects, lasting 15 to 
20 years.1,2 Dental sealants differ 
from restorative composite fill-
ings. Unfilled pit and fissure den-
tal sealants contain only the di-
methacrylate resin component of 
composite dental materials made 
of an organic monomer, bisphe-
nol A–diglycidyl methacrylate 
(bis–GMA). This is the most com-
monly used resin matrix which is 
formed by reacting glycidyl meth-
acrylate with bisphenol A (BPA).3 
Additional monomers, including 
acrylates and methacrylates, may 
be added to bis–GMA to dilute the 
resin and make the sealant materi-
al more flowable.4 One of the most 
common monomers added to bis–
GMA is BPA, which is a hormon-
ally active, synthetic chemical and 
part of a broad group of chemicals 
known as endocrine disrupting 
compounds.4 More specifically, 
BPA is a xenoestrogen, which 
mimics the relative bioactivity of 
estrogen.5
Among all xenoestrogens, BPA 
has received increased attention 
due to its pervasive presence in 
the environment and ubiquitous 
human exposure. BPA is used in 
the manufacture of polycarbon-
ate plastics and epoxy resins and 
leaches from food and beverage 
containers, baby bottles, children’s 
toys and dental sealants.6–8 BPA 
leaches from some formulations 
of dental sealants, if not completely 
polymerized, may be released into 
the oral cavity as a result of enzy-
Introduction
matic activity within saliva, and may 
be systemically absorbed by the pa-
tient.9–11
Perinatal low–dose exposure to 
BPA results in functional and mor-
phological alterations of the rodent 
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genital tract and mammary glands, 
which may predispose the tissue to 
earlier onset of disease, increased in-
fertility and mammary and prostate 
cancer, as demonstrated in vitro.12 
Fluctuations in hormonal exposure, 
especially estrogen during fetal de-
velopment, is also thought to be a 
factor in prostate, breast and uter-
ine cancers.13–16 Although research 
shows that BPA leaches from the 
dental sealant into the saliva, the 
idea that it may be absorbed systemi-
cally into the blood or may have cu-
mulative effects in the body should 
be a concern to all oral health care 
professionals because of the known 
xenoestrogenic effects of BPA.
It is crucial for dental profession-
als and the public to know if pit and 
fissure dental sealants that contain 
BPA pose a hidden risk to BPA ex-
posure. This study measured BPA in 
the serum and saliva of adults after 
placement of dental sealants and the 
rate and time BPA might be released 
from a light cured dental sealant.
Dental Sealants
Dental caries is a preventable dis-
ease, but still remains the most com-
mon chronic disease of childhood in 
the United States, occurring 5 to 8 
times more frequently than asthma, 
the second most common chronic 
childhood disease.17 According to 
Healthy People 2010, focus area 21, 
the increased use of dental sealants 
and fluoridated toothpastes, commu-
nity water fluoridation and stable di-
etary practices are all needed to con-
tinually reduce dental caries rates in 
the United States.17
Biochemistry of Dental Resin
Most dental sealants contain an or-
ganic resin matrix only, and therefore 
differ from resin composite material. 
The commonly used resin matrix 
bis–GMA has a foundational struc-
ture similar to an epoxy resin with a 
methacrylate group attached to each 
end of the carbon molecule, thus, 
bis–GMA is known as a dimethacry-
late.18 Monomers are added to dilute 
the viscous bis–GMA and enhance 



















BPA, which are 
added to bis–GMA are based on car-
bon–carbon double bonds and react 
by polymerization, which links com-
patible monomers into a larger mol-
ecule called a polymer (Figure 1). As 
a result of the process of polymeriza-
tion (curing), a chemical by–product 
is produced following the hardening 
of dental sealants.18,19 This by-prod-
uct presents itself as a tacky surface 
layer which varies in depth with dif-
ferent sealant products.20 This layer 
of unpolymerized resin has been as-
sociated with BPA controversy.
Pharmacokinetics of Bisphenol A
Olea et al8 provided one of the 
earliest cell culture studies regarding 
the possible estrogenic activity of 
both bis–GMA resin–based compos-
ites and resin–based dental sealants. 
These bis–GMA materials included 
3 different brands of composite resin 
and 2 batches of a single brand of a 
dental sealant material. To determine 
the estrogenicity of bis–GMA–based 
resins used in this study, experiments 
were conducted both in–vivo and in–
vitro. The cell yield obtained with a 
5 μg/ml sealant sample was 6–fold 
greater than in the control cultures, 
and demonstrated proliferative ef-
fects equal to the most potent estro-
gen hormone, estradiol. In contrast 
to the sealant sample, cell prolifera-
tion did not occur when exposed to 
the 3 resin–based composites at a 
maximum concentration of 1 mg/ml. 
The authors attributed these low cell 
proliferation rates of the composite 
resin to the high proportion of inor-
ganic filler used in the formulation. 
As confirmed by the analysis profile, 
BPA and BPA dimethacrylate were 
present in all sealant samples. The 
study by Olea et al8 initiated con-
cern in the dental community and 
prompted dental researchers to ex-
amine the xenoestrogen threat from 
bis–GMA–based materials used in 
dentistry.
At the inception of the current 
study, only 1 other in vivo research 
project had been reported. The study 
was conducted by Fung et al,9 and 
it evaluated whether BPA was be-
ing released from a particular dental 
sealant product. BPA in saliva was 
detected at a concentration of 5.8 
to 105.6 ppb, collected at 1 and 3 
hours after sealant application. This 
rate differed from findings of Olea et 
al, which revealed 3,300 to 30,000 
ppb.8 Fung did not detect BPA in sa-
liva after 3 hours, and was not able to 
detect the compound in blood speci-
mens.
A recent study evaluating the re-
lease of BPA following the placement 
of dental sealants was published in 
2006 by Joskow et al.11 This study 
examined 3 different brands of seal-
ant material. The researchers exam-
ined BPA in saliva and urine samples 
at varying time intervals. One of the 
sealant material released more BPA 
than the other brands of dental seal-
Figure 1. Chemical structure of 
bisphenol A and related compounds
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The repeated measures of ANOVA 
for within subject effects revealed a 
statistically significant effect of time 
on salivary BPA levels of all samples 
(Table I). Further, the t–test revealed 
a statistically significant difference 
in the salivary BPA levels between 
the 1 hour pre– and 1 hour post–den-
tal sealant placement (Table II). BPA 
was detected in all baseline saliva 
samples, and there was an increase in 
salivary BPA levels after placement 
of the dental sealant in all samples. 
The increase in BPA concentration 
readings 1 hour after sealant applica-
tion suggests that BPA was released 
from the dental sealant material.
Although only slight, the t–test 
revealed a statistically significant 
difference in the salivary BPA lev-
els between the 1 hour prior and 24 
hours post (Table 2, Figure 1). A sta-
tistically significant difference at the 
0.05 level established a difference in 
the amount of BPA detected in saliva 
Results
Prior to the start of this investiga-
tion, the protocol was reviewed and 
approved by the Old Dominion Uni-
versity Institutional Review Board 
ensuring the protection of human 
subjects. Participants comprised a 
convenience sample of 16 females 
and 14 males, 18 to 40 years of age 
with no history of dental sealants or 
composite material placement, and 
no previous exposure to BPA in its 
raw form. All data collection oc-
curred at the Old Dominion Univer-
sity Dental Hygiene Research Cen-
ter.
The researcher selected a widely 
used, commercially available light 
cured sealant material (Delton® Pit & 
Fissure Sealant – Light Cure Opaque, 
DENTSPLY Professional, York, PA). 
This sealant material uniquely con-
tained 91.2% aromatic and aliphatic 
dimethacrylate monomers, 1.5% tita-
nium dioxide (colloidal), 5.4% silica 
(colloidal), 1.0% ethyl–p–dimethyl–
aminobenzoate and <1.0% light ac-
tivators as described in the Material 
Safety Data Sheet.32
The participants were randomly 
divided into 2 groups a high–dose 
group and low–dose group. Partici-
pants were selected for each group 
based on the availability and eligi-
bility of surfaces. Subjects in the 
low–dose group received 1 occlusal 
sealant only. Subjects in the high–
dose group received 4 occlusal seal-
ants. The amount of sealant material 
placed was reflective of clinical rel-
evance and was applied according to 
the manufacturer’s instructions.
This study utilized a BPA En-
zyme Linked ImmunoSorbent Assay 
(ELISA) (Abraxis LLC, Warminster, 
Pa) to detect and quantitate levels of 
BPA in saliva and serum prior to 
and after placement of dental seal-
ants in adults. The direct competitive 
ELISA protocol was used on the rec-
ognition of BPA by specific mono-
clonal antibodies. Distinctively, the 
BPA ELISA used in this study pro-
Parametric tests were chosen to al-
low testing of multiple variables and 
their interaction. Data collected were 
analyzed using a 2 way ANOVA for 
repeated measures. Dosage was used 
as the grouping factor and time was 
the repeated factor.
T–tests provided an indication of 
significance and direction (positive 
or negative) of sample differences. 
Statistical analysis for all data was 
accomplished using the Statistical 
Analysis System, SAS® version 9.1.
ant material used in this study. The 
authors emphasized that the Ameri-
can Dental Association (ADA) only 
grants its Seal of Acceptance to those 
materials that do not release detect-
able levels of BPA (>5 ng/mL) prior 
to the cessation of this program.11,21,22 
The ADA recognizes that  laboratory 
research demonstrates a xenoestro-
genic effect from BPA that may af-
fect reproduction and development. 
Based on present research evidence, 
BPA has no effects observed in hu-
mans. Although BPA is present in 
biological specimens after the place-
ment of dental sealant, the ADA 
states that mere presence of this xe-
noestrogen in the environment or in 
human blood or urine samples “does 
not mean that the substance is neces-
sarily causing harm.”22
Effects of xenoestrogens and fluc-
tuations in estrogen exposure have 
become the focus of current research. 
Scientific data suggests that changes 
in the fetal environment may predis-
pose individuals to disease and/or or-
gan dysfunction, which may not be-
come evident until adulthood.13-15,23 
Scientists hypothesize that fetal ex-
posure to environmental estrogens 
may be the underlying cause in an 
increased incidence rate of some 
cancers, including breast and testic-
ular cancer.2,23 For example, women 
aged 40 years and older who were 
exposed in utero to diethylstilbestrol 
(DES) have a 2.5–fold increase in 
the incidence of breast cancer when 
compared to unexposed women of 
the same age.24,25
BPA is present in the environment 
and is the principal monomer used 
to manufacture polycarbonate plas-
tic at a rate of 6.4 billion lbs/year.26 
Heat and contact with acidic and ba-
sic compounds accelerate hydrolysis 
and degradation of the ester bond 
linking BPA molecules in polycar-
bonate and resins. Heating of cans 
to sterilize food and repeated wash-
ings of polycarbonate products have 
all been shown to increase exposure 
to BPA.27–29 A daily ingestion value 
can be estimated at <1 μg BPA/
kgBW/day, and is believed to be the 
main source of human exposure.27,30 
Methodology
Statistical Analysis
The U.S. Environmental Protection 
Agency estimates a safe dose calcu-
lated at 50 μg BPA/kgBW/day.31
vided a high level of sensitivity, with 
a detection range from 0.05 μg/L to 
10 μg/L and coefficient of variation 
less than 10%.
Quality control measures in-
cluded performing sample titrations 
and spike recovery tests. Results of 
the sample titration produced 82% 
of maximum binding. Spike recov-
ery tests were performed on 3 BPA 
ELISA plates to establish reliability 
and instrument validity. The aver-
age recovery rates were 86.83% and 
80.18% for the spiked serum and sa-
liva samples, respectfully.


















Figure 2. Overall Salivary BPA Concentration 
(*Indicates statistical Significant Difference Between 











Time 193.69 3 64.56 90.32 <.0001
















Table II. T–Test Results for Salivary BPA at the 1 
hour Prior, 1 hour, 3 hours and 24 hours Post Time 
Periods











84.38 1 84.38 11.12 <.0001
Table III. Analysis of Variance Test for Salivary BPA 
Levels Between Low–Dose and High–Dose Groups
samples 1 hour prior to and 1 hour, 3 
hours and 24 hours post–dental seal-
ant placement in all samples. The se-
rum BPA levels were below the limit 
of quantitation (<0.05 ng/mL).
The repeated measures of ANO-
VA for between subjects effects re-
vealed a statistically significant ef-
fect of dose on salivary BPA levels 
(F=11.12, p=<.0001) (Table III). A 
post–hoc test (Tukey’s) revealed a 
statistically significant difference 
between the mean salivary BPA con-
centration levels in the low–dose 
and high–dose groups at both the 1 
hour (p=<.0001) and 3 hours post 
(p=0.0027) time periods. No sta-
tistically significant difference was 
revealed between the mean salivary 
BPA concentration levels in the low–
dose and high–dose groups at either 
1 hour prior (p=0.4328) or 24 hours 
post (p=0.3283) time periods. Figure 
1 displays the mean BPA levels for 
both low and high–dose groups at all 
time periods.
This exploratory investigation 
replicated the in vivo study con-
ducted by Fung, et al.9 Analysis of 
saliva samples at baseline revealed 
detectible levels of BPA (0.06 to 
4.02 ng/mL) in each of the 30 sam-
ples measured 1 hour prior to dental 
sealant placement. The detection of 
salivary BPA in every participant 
suggests either short term or long 
term exposure levels. Detection 
of BPA in baseline readings from 
the current study differed from the 
findings of Fung et al, which did 
not detect salivary levels of BPA in 
any baseline samples.9
In vivo results from the current 
study, Fung et al9 and Joscow et al11 
consistently reveal detectible lev-
els of BPA in saliva at the 1 hour 
and 3 hours post–sealant applica-
tion collection times, thus indicat-
ing the release of unpolymerized 
or leachable BPA from the same 
dental sealant material used in all 
4 studies.8,9,11 The dental sealant 
material used in all 4 studies con-
tained bis–GMA combined with an 
additional monomer, BPA, result-
Discussion
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Conclusion
Dental professionals should re-
duce BPA exposure to patients from 
dental sealants by using products 
that have the ADA Seal of Accep-
ing in bisphenol A dimethacrylate 
(BPDMA, bis–DMA) ), however, 
the manufacturer’s of these dental 
sealant products maintain the spe-
cific proprietary chemical formula-
tion.
Salivary BPA levels demonstrate 
a peak level between the 1 hour and 
3 hour post–application collection 
time. BPA levels began to reduce 
in concentration between the 3 
hour and 24 hour post–application 
collection times, almost equating 
baseline with the final collection.
There was no BPA detected in 
the serum samples collected at the 
1 hour and 3 hour post sealant ap-
plication times. These findings are 
similar to those of Fung et al,8 who 
did not detect BPA in any of the 
serum specimens examined in the 
study.9 Implications from the find-
ings of this study are that BPA is 
not absorbed into the blood circu-
latory system after exposure has 
occurred from the dental sealant 
formula used in this and previous 
studies.
Although not statistically signif-
icant, salivary BPA levels were dif-
ferent between the low–dose and 
high–dose groups when measured 
at baseline. This finding indicates a 
possible influence from an extrane-
ous variable such as age. Additional 
extraneous variables that may have 
influenced differing salivary BPA 
levels between the low–dose and 
high–dose groups include gender, 
ethnicity and other demographic 
variables.
The specific molecular formula-
tion of dental sealant material dif-
fers between manufactured brands 
of dental sealants, depending on 
chemical additives to bis–GMA4 
and may not be recognized by 
dental professionals. The amount 
of BPA exposure encountered in 
this study is below the allowable 
safe dosage/day as established by 
the U.S. Environmental Protection 
Agency, calculated at 50 μg BPA/
kgBW/day.31,33,34 It has not been 
established that this level of short-
term (24–hour) exposure causes ir-
reversible damage or poses a true 
health threat. Further research is 
needed to establish health effects 
of this short–term exposure.
National data confirms that 80% 
of dental caries risk is among chil-
dren and the adolescent popula-
tion, known as a focus group of 
dental sealants.17 Considering seal-
ants are applied during these ado-
lescent, pubescent years of devel-
opment, all precautions to reduce 
BPA exposure should be taken. It 
is important that dental profession-
als still apply dental sealants in the 
nation-wide effort to reduce dental 
decay.
Dental sealant formulations dif-
fer among manufacturers and may 
not directly specify if BPA was a 
precursor included in the founda-
tional  bis-GMA product, or if it 
was added as a monomer. BPA may 
not be indicated as a direct ingredi-
ent indicated on the Material Safety 
Data Sheet. Therefore, dental pro-
fessionals should consult with each 
individual sealant material manu-
facturer and frequently review each 
product among the evidence-based 
clinical and laboratory research. To 
further reduce BPA exposure after 
sealant application, a pumice wash 
should be delivered to the surface 
with a prophylactic rubber cup and 
followed by a water rinse.35,36
tance and adopt the accepted proto-
cols for use. Future research should 
investigate the cumulative exposure 
effects of BPA on humans from den-
tal sealants considering environmen-
tal influences. Studies should also 
analyze existing demographic data 
generated in this study to determine 
if there is a relationship between sal-
ivary BPA concentration levels and 
gender, ethnicity, age, marital status 
or household income. Replication of 
this study is recommended, using a 
larger sample population and analy-
sis of biological specimens includ-
ing semen, vaginal fluid, dental pulp 
tissue and hair follicles.
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